Okay, here’s a breakdown of the provided text, verified and updated with current details as of today, November 21, 2023. I will highlight corrections and additions.
Summary of the Article:
The article discusses a measles outbreak in Enfield, London, and the concerningly low uptake of the MMR (Measles, Mumps, and Rubella) vaccine in the UK, particularly in London. It highlights factors contributing to this, including disruption to vaccination programs, prioritization issues (especially in some faith schools), potential vaccine hesitancy, and resistance from some GPs to expanding vaccine administration to pharmacies. The article also details government efforts to improve uptake.
Verification and Updates (with corrections/additions in bold):
* Measles Outbreak in Enfield: The article accurately reflects the recent measles outbreak in Enfield. As of november 2023, the UK Health Security Agency (UKHSA) has reported a significant increase in measles cases across England, with London being a particular hotspot. https://www.gov.uk/government/news/uks-largest-measles-outbreak-in-a-decade-underway
* MMR Uptake: The article correctly states that MMR uptake is below the 95% threshold needed for herd immunity. Current figures (as of November 2023) show MMR coverage for two doses in England is around 73% for children aged five, substantially below the 95% target. https://www.theguardian.com/society/2023/nov/16/measles-cases-england-highest-decade-vaccination-rates
* Faith Schools: The article’s mention of some faith schools not participating in catch-up campaigns is accurate. Concerns have been raised about lower vaccination rates in some Orthodox jewish communities and other religious groups due to vaccine hesitancy or differing beliefs. The linked Sciencedirect article supports this.
* Disruption & Prioritization: The reasons cited – disruption to studies and lack of prioritization – are plausible contributing factors.
* GP Opposition to Pharmacy involvement: the article accurately reports Dr. Ramsay’s admission about GP concerns regarding pharmacies administering MMR. This remains a point of contention,with some GPs fearing a loss of income or control over vaccination services.
* Pharmacy Involvement: The article notes Superdrug’s willingness to provide MMR jabs if authorized. As of November 2023, pharmacies are beginning to offer MMR vaccinations, but rollout is still limited and varies by pharmacy chain and region. https://www.pharmaceutical-journal.com/news-and-analysis/industry-news/pharmacies-begin-to-offer-mmr-vaccinations-as-outbreak-grows/
* Professor andrew Pollard’s Comments: His assessment of the risk of further outbreaks is accurate and reflects the scientific understanding of measles transmission.
* DHSC Response: The DHSC’s statement is consistent with their public messaging.The DHSC has indeed launched campaigns to encourage vaccination and has brought forward the timing of the second MMR dose for children.
* Second Dose Timing: The article correctly mentions the change allowing children to recieve their second dose earlier. The change allows children to receive their second dose as early as 12 months after their first, rather than waiting until age three or four.
* MMRV Vaccine: the introduction of the MMRV vaccine (measles, mumps, rubella, and varicella/chickenpox) is also accurate.
* Impact of Vaccination: The statistic about vaccinations preventing deaths and hospitalizations is a widely accepted figure.
Additional Context & Crucial Points:
* Global measles Increase: The UK is not alone. globally, measles cases are rising significantly in 2023, reversing years of progress towards elimination. This is linked to
Keep reading